Predictors identified for losses to follow-up among HIV-seropositive patients

被引:76
作者
Lanoy, Emilie
Mary-Krause, Murielle
Tattevin, Pierre
Dray-Spira, Rosemary
Duvivier, Claudine
Fischer, Patricia
Obadia, Yolande
Lert, France
Costagliola, Dominique
机构
[1] INSERM, U720, F-75625 Paris 13, France
[2] Univ Paris 06, F-75013 Paris, France
[3] CHU Pontchaillou, Serv Malad Infect & Reanimat Med, Rennes, France
[4] INSERM, U687, F-94410 St Maurice, France
[5] Hop La Pitie Salpetriere, Dept Malad Infect & Trop, Paris, France
[6] CHRU Strasbourg, Antenne Immunooncohematol, Strasbourg, France
[7] INSERM, U379, F-13006 Marseille, France
关键词
bias; clinical management; cohort data; HIV infection; loss to follow-up;
D O I
10.1016/j.jclinepi.2005.11.024
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and Objective: This study aims to describe predictors of loss to follow-up (LFU) in the French Hospital Database on HIV infection (FHDH). Methods: We studied the prevalence and predictors of LFU among 34,835 patients enrolled in FHDH in 1999. Impacts of demographic and clinical factors were studied by using multivariate logistic regression analysis. Results: Among included patients, 1,478 (4.2%) died and 2,950 (8.5%) were lost to follow-up. LFU was more frequent among recently diagnosed patients (<1 year, 16.8%; >1 year, 7.1). Among recently diagnosed patients, LFU was less frequent among men who have sex with men (MSM) [odds radio (OR) = 0.6, 95% confidence interval (CI) = (0.5;0.7)], and among patients with AIDS [OR = 0.5, 95% CI = (0.4,0.6)], and more frequent among immigrants [OR = 1.3, 95%CI = (1.0;1.5)]. Among less recently diagnosed patients, LFU was more frequent in French Departments of America than in the Paris area. The proportion of LFU fell with age, and LFU was more frequent among intravenous drug users (IVDU) than among MSM [OR = 1.2, 95%CI = (1.1;1.4)]. Patients with viral load >5,000 copies/mL or CD4 cell counts <200/mm(3) were more likely to be lost to follow-up. Conclusions: Recently diagnosed patients, IVDU, and immigrants are more often lost to follow-up, and should therefore receive special attention. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:829 / 835
页数:7
相关论文
共 25 条
[1]   EXPANDED EUROPEAN AIDS CASE DEFINITION [J].
ANCELLEPARK, R .
LANCET, 1993, 341 (8842) :441-441
[2]   Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from sub-Saharan Africa [J].
Anglaret, X ;
Toure, S ;
Gourvellec, G ;
Tchehy, A ;
Zio, L ;
Zaho, M ;
Kassi, MC ;
Lehou, J ;
Coulibaly, H ;
Seyler, C ;
N'Dri-Yoman, T ;
Salamon, R ;
Chêne, G .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (03) :320-323
[3]   Record-linkage between two anonymous databases for a capture-recapture estimation of underreporting of AIDS cases: France 1990-1993 [J].
Bernillon, P ;
Lievre, L ;
Pillonel, J ;
Laporte, A ;
Costagliola, D .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2000, 29 (01) :168-174
[4]   Nonadherence among HIV-Infected injecting drug users: The impact of social instability [J].
Bouhnik, AD ;
Chesney, M ;
Carrieri, P ;
Gallais, H ;
Moreau, J ;
Moatti, JP ;
Obadia, Y ;
Spire, B .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S149-S153
[5]  
BOZETTE SA, 2000, NEW ENGL J MED, V348, P702
[6]  
Cohen ER, 1999, PHYS TODAY, V52, pBG5
[7]   Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers [J].
Cottler, LB ;
Compton, WM ;
BenAbdallah, A ;
Horne, M ;
Claverie, D .
DRUG AND ALCOHOL DEPENDENCE, 1996, 41 (03) :209-217
[8]   Combination antiretroviral therapy and the risk of myocardial infarction [J].
Friis-Moller, N ;
Sabin, CA ;
Weber, R ;
Monforte, AD ;
El-Sadr, WM ;
Reiss, P ;
Thiébaut, R ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Lundgren, JD ;
Lundgren, JD ;
Weber, R ;
Monteforte, AD ;
Bartsch, G ;
Reiss, P ;
Dabis, F ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Houyez, F ;
Loeliger, E ;
Tressler, R ;
Weller, I ;
Friis-Moller, N ;
Sabin, CA ;
Sjol, A ;
Lundgren, JD ;
Sawitz, A ;
Rickenbach, M ;
Pezzotti, P ;
Krum, E ;
Meester, R ;
Lavignolle, V ;
Sundström, A ;
Poll, B ;
Fontas, E ;
Torres, F ;
Petoumenos, K ;
Kjær, J ;
Hammer, S ;
Neaton, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :1993-2003
[9]   Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients [J].
Herida, M ;
Mary-Krause, M ;
Kaphan, R ;
Cadranel, J ;
Poizot-Martin, I ;
Rabaud, C ;
Plaisance, N ;
Tissot-Dupont, H ;
Boue, F ;
Lang, JM ;
Costagliola, D .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) :3447-3453
[10]   Retention of women enrolled in a prospective study of human immunodeficiency virus infection: Impact of race, unstable housing, and use of human immunodeficiency virus therapy [J].
Hessol, NA ;
Schneider, M ;
Greenblatt, RM ;
Bacon, M ;
Barranday, Y ;
Holman, S ;
Robison, E ;
Williams, C ;
Cohen, M ;
Weber, K .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 154 (06) :563-573